Ignite Creation Date:
2025-12-25 @ 1:11 AM
Ignite Modification Date:
2026-06-20 @ 9:09 AM
Study NCT ID:
NCT06745193
Status:
NOT_YET_RECRUITING
Last Update Posted:
2024-12-20
First Post:
2024-12-17
Is NOT Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
A Prospective, Randomized, Open, Phase II Clinical Study of Chidamide in Combination with Camrelizumab and Apatinib for Advanced Esophageal Cancer
Sponsor:
Peking University
Organization:
Organization Data
Organization:
Class:
OTHER
Study ID:
CSIIT-Q73
Study Type:
None
Study Domain:
None
Study Link:
None
Lead Sponsor:
Lead Sponsor Class:
OTHER
Responsible Party:
Responsible Party Title:
Responsible Party Type:
SPONSOR
Responsible Party Affiliation:
Old Name:
None
Old Organization:
None